Haematologica
(Mar 2020)
Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center
Yucai Wang,
Marcella A. Tschautscher,
Kari G. Rabe,
Timothy G. Call,
Jose F. Leis,
Saad S. Kenderian,
Neil E. Kay,
Eli Muchtar,
Daniel L. Van Dyke,
Amber B. Koehler,
Susan M. Schwager,
Susan L. Slager,
Sameer A. Parikh,
Wei Ding
Affiliations
Yucai Wang
Division of Hematology, Mayo Clinic, Rochester, MN
Marcella A. Tschautscher
Division of Hematology, Mayo Clinic, Rochester, MN
Kari G. Rabe
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
Timothy G. Call
Division of Hematology, Mayo Clinic, Rochester, MN
Jose F. Leis
Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
Saad S. Kenderian
Division of Hematology, Mayo Clinic, Rochester, MN
Neil E. Kay
Division of Hematology, Mayo Clinic, Rochester, MN
Eli Muchtar
Division of Hematology, Mayo Clinic, Rochester, MN
Daniel L. Van Dyke
Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN, USA
Amber B. Koehler
Division of Hematology, Mayo Clinic, Rochester, MN
Susan M. Schwager
Division of Hematology, Mayo Clinic, Rochester, MN
Susan L. Slager
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
Sameer A. Parikh
Division of Hematology, Mayo Clinic, Rochester, MN
Wei Ding
Division of Hematology, Mayo Clinic, Rochester, MN
DOI
https://doi.org/10.3324/haematol.2019.224121
Journal volume & issue
Vol. 105,
no. 3
Abstract
Read online
The natural history, prognostication and optimal treatment of Richter transformation developed from chronic lymphocytic leukemia (CLL) are not well defined. We report the clinical characteristics and outcomes of a large series of biopsy-confirmed Richter transformation (diffuse large B-cell lymphoma or high grade B-cell lymphoma, n=204) cases diagnosed from 1993 to 2018. After a median follow up of 67.0 months, the median overall survival (OS) was 12.0 months. Patients who received no prior treatment for CLL had significantly better OS (median 46.3 vs. 7.8 months; P
Published in Haematologica
ISSN
0390-6078 (Print)
1592-8721 (Online)
Publisher
Ferrata Storti Foundation
Country of publisher
Italy
LCC subjects
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website
http://www.haematologica.org
About the journal
WeChat QR code
Close